HP Inc on Tuesday missed Wall Street targets for second-quarter revenue, hurt by a slowdown in the personal computer market as inflation-hit customers tightened their budgets.
Global PC shipments declined nearly 30 per cent in the January-March period to levels lower than before the pandemic, according to data from research firm IDC. HP said it expects second-half revenue to be higher than the first half, even though the year-on-year comparison will still be negative. The PC maker now expects annual adjusted profit between $3.30 per share and $3.50 per share, compared with $3.20 to $3.60 forecast earlier.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China's Great Wall Motor plans EV battery assembly, research in ThailandBANGKOK : China's Great Wall Motor Co Ltd is finalising plans to invest up to $30 million to set up a new battery pack assembly plant in Thailand, where it will start making a compact electric car next year, according to a company official.The Hebei-based company is also considering establishing a researc
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
China's Great Wall Motor plans EV battery assembly, research in ThailandBANGKOK: China's Great Wall Motor is finalising plans to invest up to US$30 million to set up a new battery pack assembly plant in Thailand, where it will start making a compact electric car next year, according to a company official. The Hebei-based company is also considering establishing a research and
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer, Moderna hit with new Alnylam patent lawsuits over Covid-19 vaccinesBiotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday (May 26) against Pfizer Inc and Moderna Inc in Delaware federal court, again claiming that the companies' Covid-19 vaccines infringe its patents. The new lawsuits mark the third time Alnylam has sued Pfizer and Moderna in Delaware for allegedly violating its patent rights in lipid nanoparticle (LNP) technology, which the...
Source: asiaonecom - 🏆 10. / 59 Read more »